Qiming Venture Partners Portfolio Companies Zhipu AI and Shengshu Technology Forge Strategic Partnership to Advance Domestic Large Model Innovation and Industrial Deployment
The two parties will jointly explore forward-looking AI technology innovations and collaborate to empower intelligent transformation across all industries.

Recently, two Qiming Venture Partners portfolio companies, Zhipu AI and Shengshu Technology, announced a strategic partnership to combine their respective strengths in large language models and multimodal generative models. The collaboration will span joint R&D, product integration, solution bundling, and industry coordination to advance the innovation and commercial adoption of domestic large models.

Per the strategic agreement, on the product front, Zhipu AI's MaaS platform will integrate Shengshu Technology's Vidu API, incorporating Vidu's video generation capabilities to serve a broader base of developers and enterprise clients. For solution integration, both parties will leverage their respective expertise to build more competitive technical solutions for key industries. On industry coordination, the partnership will focus on verticals including government and enterprise services, consumer internet, culture and tourism, advertising and marketing, animation and film, and broadcasting media — jointly developing AI-powered innovative applications that meet diverse industry demands and driving large-scale technology deployment in priority sectors.
On joint R&D, Zhipu AI develops the proprietary GLM large model series and holds a leading position in language and multimodal models, with its open-source video generation model CogVideoX garnering over 10,000 stars on GitHub. Shengshu Technology focuses on independently developing multimodal general-purpose large models, offering leading video generation and multimodal generation products.

As two Tsinghua University-affiliated AI leaders in China, Zhipu AI and Shengshu Technology's strategic alliance in multimodal technology will not only further elevate the comprehensive capabilities and technical leadership of domestic large models, but also foster healthy collaborative innovation and prosperous development across China's large model ecosystem.
Previously
Qiming Stars | Zhipu AI Launches AutoGLM, GLM's First Productized Agent, Ushering in AI's "Phone Use" Moment Qiming Stars | Shengshu Technology and Tsinghua University Launch Vidu, China's First Fully Self-Developed Video Foundation Model, as Full Sora Competitor Qiming Viewpoint | Alex Zhou, Qiming Venture Partners: A "Super AI App" Will Likely Emerge This Year

Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since inception, the firm has focused on investing in outstanding early and growth-stage companies in Technology and Consumer (T&C) and Healthcare sectors.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, with more than 210 exiting via listings on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), Sinocelltech (688520.SH), Yuanxin Technology, ClinChoice, Belief BioMed, Biren Technology, and others.